サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1434618

アレルギー診断薬市場：タイプ別、製品タイプ別、検査別、エンドユーザー別-2024-2030年の世界予測

Allergy Diagnostics Market by Type (Drug Allergen, Food Allergen, Inhaled Allergen), Product Type (Assay Kits, Consumables, Instruments), Test, End User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 187 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
アレルギー診断薬市場：タイプ別、製品タイプ別、検査別、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 187 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アレルギー診断薬市場規模は2023年に59億2,000万米ドルと推計され、2024年には64億9,000万米ドルに達し、CAGR 10.35%で2030年には118億米ドルに達すると予測されます。

アレルギー診断薬の世界市場

主な市場の統計
基準年[2023］ 59億2,000万米ドル
予測年[2024］ 64億9,000万米ドル
予測年 [2030] 118億米ドル
CAGR（%） 10.35%
アレルギー診断薬 Market-IMG1

アレルギー診断とは、患者の身体が既知の化学物質に対してアレルギーを持っているかどうかを判断するために、資格を持った専門家によって行われる検査です。アレルギー診断薬検査では、アレルギーに関連する体内の典型的な抗体やタンパク質の数を推定します。アトピー性皮膚炎、じんましん、アレルギー性結膜炎などのアレルギー疾患の増加により、正確なアレルギー診断の必要性が高まると予想されます。人口の間で複数のアレルギー疾患が発生することで、アレルゲンの早期発見と診断への嗜好が拡大し、効果的な診断検査やシステムの必要性が生じています。しかし、アレルギー疾患に対する認識が限定的であること、診断検査にかかるコストが高いこと、訓練を受けた専門家が限られていることなどが、予測期間中の市場開拓の妨げになる可能性があります。さらに、企業がAIやMLに基づく新しいアレルギー診断検査やキットを開発する研究活動に重点を置き始めていることが、市場開発の機会を生み出しています。

地域別洞察

欧州は製薬産業が発達し、治療薬の需要が増加しているため、アレルギー診断薬市場において重要な地位を占めています。高齢者人口の増加とアレルギー疾患の増加も同地域の成長に寄与しています。南北アメリカでは、呼吸器系アレルギー疾患の発生率の高さ、アレルギー診断薬に関する意識レベルの上昇、試験管内血液検査の採用により、今後数年間で市場の成長が見込まれます。FDAは食品業界、消費者、その他の利害関係者に対し、食品中のアレルゲンの危険性を評価し管理する最良の方法を指導してきました。生物製剤評価研究センター（CBER）は、北米の市場成長に貢献したいくつかのアレルゲン製品を規制しています。アジア太平洋は、急速に改善するヘルスケア・インフラ、アンメット・クリニカル・ニーズ、低侵襲診断ツールの需要により、最も急成長する地域市場になると予想されます。サウジアラビアは、アレルギー診断薬に必要な機器や消耗品の主要部分をUAEが製造・輸出しているため、アレルギー診断薬市場において成長が見込まれています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはアレルギー診断薬市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、アレルギー診断薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-アレルギー診断薬市場の市場規模および予測は？

2-アレルギー診断薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-アレルギー診断薬市場における技術動向と規制の枠組みは？

4-アレルギー診断薬市場における主要ベンダーの市場シェアは？

5-アレルギー診断薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 食物アレルギー、アレルギー性鼻炎、喘息の有病率の増加
      • 体外診断用血液検査に対する患者の需要の高まり
      • アレルギー診断検査に対する有利な償還ポリシー
    • 抑制要因
      • アレルギー診断の不正確さに関連する問題
    • 機会
      • 感度特異性の向上と診断の迅速化によるアレルギー診断製品の進歩
      • 医薬品開発のための研究開発の取り組みが増加
    • 課題
      • 標準化された診断基準の欠如と、訓練を受けた専門家の確保が限られている
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 アレルギー診断薬市場：タイプ別

  • 薬物アレルゲン
  • 食物アレルゲン
  • 吸入アレルゲン

第7章 アレルギー診断薬市場：製品タイプ別

  • アッセイキット
  • 消耗品
  • 機器
    • 免疫測定分析装置
    • 照度計

第8章 アレルギー診断薬市場テスト別

  • 体外検査
  • インビボ検査

第9章 アレルギー診断薬市場：エンドユーザー別

  • 学術調査機関
  • 診断研究所
  • 病院ベースの検査機関

第10章 南北アメリカのアレルギー診断薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のアレルギー診断薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのアレルギー診断薬市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析
    • 合併・買収
    • 新製品発売と機能強化
    • 投資、資金調達
    • 受賞・表彰・拡大

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • ALK-Abello A/S
    • Allergy Therapeutics PLC
    • Astra Biotech GmbH
    • Bausch & Lomb Incorporated
    • Biomerieux SA
    • Danaher Corporation
    • Dr. Fooke-Achterrath Laboratorien GmbH
    • DST Diagnostische Systeme & Technologien GmbH
    • Erba Group
    • Eurofins Scientific
    • EUROIMMUN Medizinische Labordiagnostika AG
    • HAL Allergy B.V.
    • Hitachi, Ltd.
    • HOB Biotech Group Corp., Ltd.
    • HollisterStier by Jubilant Life Sciences Limited
    • HYCOR Biomedical
    • Lincoln Diagnostics, Inc.
    • Minaris Medical America, Inc.
    • Neogen Corporation
    • Omega Diagnostics Group PLC
    • Parkway Pantai Ltd.
    • R-Biopharm AG
    • Romer Labs Division Holding GmbH by Royal DSM
    • ROXALL Medizin GmbH
    • Siemens AG
    • Stallergenes Greer International AG
    • Tecan Trading AG
    • Thermo Fisher Scientific Inc.
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ALLERGY DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. ALLERGY DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ALLERGY DIAGNOSTICS MARKET DYNAMICS
  • FIGURE 7. ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 10. ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2030 (%)
  • FIGURE 12. ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ALLERGY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. ALLERGY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ALLERGY DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ALLERGY DIAGNOSTICS MARKET SIZE, BY DRUG ALLERGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ALLERGY DIAGNOSTICS MARKET SIZE, BY FOOD ALLERGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ALLERGY DIAGNOSTICS MARKET SIZE, BY INHALED ALLERGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 10. ALLERGY DIAGNOSTICS MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ALLERGY DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 14. ALLERGY DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ALLERGY DIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 17. ALLERGY DIAGNOSTICS MARKET SIZE, BY IN-VITRO TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ALLERGY DIAGNOSTICS MARKET SIZE, BY IN-VIVO TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. ALLERGY DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ALLERGY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ALLERGY DIAGNOSTICS MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. ALLERGY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 233. ALLERGY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 234. ALLERGY DIAGNOSTICS MARKET LICENSE & PRICING
目次
Product Code: MRR-436901065A3F

[187 Pages Report] The Allergy Diagnostics Market size was estimated at USD 5.92 billion in 2023 and expected to reach USD 6.49 billion in 2024, at a CAGR 10.35% to reach USD 11.80 billion by 2030.

Global Allergy Diagnostics Market

KEY MARKET STATISTICS
Base Year [2023] USD 5.92 billion
Estimated Year [2024] USD 6.49 billion
Forecast Year [2030] USD 11.80 billion
CAGR (%) 10.35%
Allergy Diagnostics Market - IMG1

An allergy diagnosis is a test performed by a qualified specialist to determine if the patient's body is allergic to known chemicals. Allergy diagnostics tests estimate the number of typical antibodies or proteins in the body that are associated with allergies. Rising cases of allergic diseases such as atopic dermatitis, hives, and allergic conjunctivitis are expected to elevate the need for accurate allergy diagnosis. The incidence of multiple allergic diseases among the population expands the preference for early detection and diagnosis of the allergen, creating a requirement for effective diagnostic tests or systems. However, limited awareness about allergic diseases and high costs of diagnostic tests, and the limited availability of trained professionals can impede the market development over the forecast period. Furthermore, the emerging emphasis on research activities to develop new allergy diagnostic tests or kits based on AI and ML by companies is creating an opportunity for market development.

Regional Insights

Europe has a significant landscape in the allergy diagnostics market due to a developed pharmaceutical industry and increasing demand for therapeutics. The growing geriatric population and rising incidences of allergic conditions also contribute to the region's growth. The market is expected to grow in the Americas in coming years owing to the high incidence of respiratory allergic disorders, rising awareness levels about allergy diagnostics, and the adoption of in vitro blood tests. The FDA has guided the food industry, consumers, and other stakeholders on the best ways to assess and manage allergen hazards in food. The Center for Biologics Evaluation and Research (CBER) regulates several allergenic products that contributed to market growth in North America. Asia-Pacific is expected to be the fastest-growing regional market due to rapidly improving healthcare infrastructure, unmet clinical needs, and demand for minimally invasive diagnostic tools. Saudi Arabia has a growing landscape in the allergy diagnostics market, as the UAE manufactures and exports major parts of instruments and consumables required for allergy diagnostics.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Allergy Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Allergy Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Allergy Diagnostics Market, highlighting leading vendors and their innovative profiles. These include ALK-Abello A/S, Allergy Therapeutics PLC, Astra Biotech GmbH, Bausch & Lomb Incorporated, Biomerieux SA, Danaher Corporation, Dr. Fooke-Achterrath Laboratorien GmbH, DST Diagnostische Systeme & Technologien GmbH, Erba Group, Eurofins Scientific, EUROIMMUN Medizinische Labordiagnostika AG, HAL Allergy B.V., Hitachi, Ltd., HOB Biotech Group Corp., Ltd., HollisterStier by Jubilant Life Sciences Limited, HYCOR Biomedical, Lincoln Diagnostics, Inc., Minaris Medical America, Inc., Neogen Corporation, Omega Diagnostics Group PLC, Parkway Pantai Ltd., R-Biopharm AG, Romer Labs Division Holding GmbH by Royal DSM, ROXALL Medizin GmbH, Siemens AG, Stallergenes Greer International AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Allergy Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Drug Allergen
    • Food Allergen
    • Inhaled Allergen
  • Product Type
    • Assay Kits
    • Consumables
    • Instruments
      • Immunoassay Analyzers
      • Luminometers
  • Test
    • In-Vitro Tests
    • In-Vivo Tests
  • End User
    • Academic Research Institutes
    • Diagnostic Laboratories
    • Hospital-Based Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Allergy Diagnostics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Allergy Diagnostics Market?

3. What are the technology trends and regulatory frameworks in the Allergy Diagnostics Market?

4. What is the market share of the leading vendors in the Allergy Diagnostics Market?

5. Which modes and strategic moves are suitable for entering the Allergy Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Allergy Diagnostics Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of food allergies, allergic rhinitis, and asthma
      • 5.1.1.2. Rising patient demand for in vitro diagnostic blood tests
      • 5.1.1.3. Favorable reimbursement policies for allergy diagnostic tests
    • 5.1.2. Restraints
      • 5.1.2.1. Issues related to inaccuracy in allergic diagnosis
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement in allergic diagnosis products with enhanced sensitivity specificity and faster diagnosis
      • 5.1.3.2. Increasing number of research and development initiatives for the development of drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardized diagnostic criteria coupled with limited availability of trained professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Allergy Diagnostics Market, by Type

  • 6.1. Introduction
  • 6.2. Drug Allergen
  • 6.3. Food Allergen
  • 6.4. Inhaled Allergen

7. Allergy Diagnostics Market, by Product Type

  • 7.1. Introduction
  • 7.2. Assay Kits
  • 7.3. Consumables
  • 7.4. Instruments
    • 7.5.1. Immunoassay Analyzers
    • 7.5.2. Luminometers

8. Allergy Diagnostics Market, by Test

  • 8.1. Introduction
  • 8.2. In-Vitro Tests
  • 8.3. In-Vivo Tests

9. Allergy Diagnostics Market, by End User

  • 9.1. Introduction
  • 9.2. Academic Research Institutes
  • 9.3. Diagnostic Laboratories
  • 9.4. Hospital-Based Laboratories

10. Americas Allergy Diagnostics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Allergy Diagnostics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Allergy Diagnostics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Merger & Acquisition
      • 13.3.1.1. ModMed® Acquires Software from Xtract Solutions to build premier solution in allergy
      • 13.3.1.2. Vimian Group Acquires Veterinary Allergy company in Denmark
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. Amulet Launches to Bring Powerful detection out of the lab and into the hands of millions
      • 13.3.2.2. Wellnow Allergy launches in liverpool to bring convenience to allergy testing and immunotherapy
    • 13.3.3. Investment & Funding
      • 13.3.3.1. This allergy drop startup raises $2M to bring at-home allergy testing to everyone
      • 13.3.3.2. Home allergy testing company Nectar secures $16.5M in funding
    • 13.3.4. Award, Recognition, & Expansion
      • 13.3.4.1. AllerVie Health acquires Allergy, Sinus & Asthma family health center, densifies footprint in the villages, Florida
      • 13.3.4.2. Siemens launches centre of excellence for immunoassay instrument R&D in Ireland
      • 13.3.4.3. Reacta secures US patent for food allergy diagnostics

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. ALK-Abello A/S
    • 14.1.2. Allergy Therapeutics PLC
    • 14.1.3. Astra Biotech GmbH
    • 14.1.4. Bausch & Lomb Incorporated
    • 14.1.5. Biomerieux SA
    • 14.1.6. Danaher Corporation
    • 14.1.7. Dr. Fooke-Achterrath Laboratorien GmbH
    • 14.1.8. DST Diagnostische Systeme & Technologien GmbH
    • 14.1.9. Erba Group
    • 14.1.10. Eurofins Scientific
    • 14.1.11. EUROIMMUN Medizinische Labordiagnostika AG
    • 14.1.12. HAL Allergy B.V.
    • 14.1.13. Hitachi, Ltd.
    • 14.1.14. HOB Biotech Group Corp., Ltd.
    • 14.1.15. HollisterStier by Jubilant Life Sciences Limited
    • 14.1.16. HYCOR Biomedical
    • 14.1.17. Lincoln Diagnostics, Inc.
    • 14.1.18. Minaris Medical America, Inc.
    • 14.1.19. Neogen Corporation
    • 14.1.20. Omega Diagnostics Group PLC
    • 14.1.21. Parkway Pantai Ltd.
    • 14.1.22. R-Biopharm AG
    • 14.1.23. Romer Labs Division Holding GmbH by Royal DSM
    • 14.1.24. ROXALL Medizin GmbH
    • 14.1.25. Siemens AG
    • 14.1.26. Stallergenes Greer International AG
    • 14.1.27. Tecan Trading AG
    • 14.1.28. Thermo Fisher Scientific Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing